Akseli Hemminki
Gründer bei TILT Biotherapeutics Oy
Profil
Akseli Hemminki is the founder of TILT Biotherapeutics Oy, where he currently serves as the Chief Executive Officer & Director.
TILT Biotherapeutics Oy was founded in 2013.
Dr. Hemminki is also the founder of Targovax Oy.
In addition to his founding positions, Dr. Hemminki has worked as a Research Team Leader at The University of Alabama.
Aktive Positionen von Akseli Hemminki
| Unternehmen | Position | Beginn |
|---|---|---|
TILT Biotherapeutics Oy
 TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology TILT Biotherapeutics Oy is a preclinical stage company working in the field of cancer immunotherapy. It develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment. The company was founded by Akseli Hemminki in 2013 and is headquartered in Helsinki, Finland. | Gründer | 01.01.2013 |
Ehemalige bekannte Positionen von Akseli Hemminki
| Unternehmen | Position | Ende |
|---|---|---|
| The University of Alabama | Corporate Officer/Principal | - |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Targovax Oy
Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Health Technology |
TILT Biotherapeutics Oy
TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology TILT Biotherapeutics Oy is a preclinical stage company working in the field of cancer immunotherapy. It develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment. The company was founded by Akseli Hemminki in 2013 and is headquartered in Helsinki, Finland. | Health Technology |
